News
SOPH
2.690
+2.28%
0.060
SOPHiA GENETICS partnering with Boundless Bio on oncogene cancer therapies
SOPHiA GENETICS (NASDAQ:SOPH) has entered a partnership with p...
Seekingalpha · 09/21 13:30
SOPHiA GENETICS Unveils Strategy to Drive Health Care Innovations at Inaugural Investor Day Event
Highlights include: a memorandum of understanding with Memorial Sloan Kettering Cancer Center and a novel new partnership with Boundless Bio, a next-generation precision oncology company SOPHiA GENETICS’ next-generation solution CarePath, fueled by current...
GlobeNewswire · 09/21 11:02
SOPHiA GENETICS to Highlight Innovations and Announcements at Investor Day on September 20, 2022
BOSTON and GENEVA, Switzerland, Sept. 20, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, will host its first-ever Investor Day TODAY in-person at PUBLIC Hotel in New York City. The event wi...
GlobeNewswire · 09/20 10:43
SOPHiA GENETICS to Participate in Fireside Chat at 20th Annual Morgan Stanley Global Healthcare Conference
BOSTON and LAUSANNE, Switzerland, Sept. 02, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today Chief Executive Officer, Dr. Jurgi Camblong and Chief Financial Officer, Ross M...
GlobeNewswire · 09/02 11:00
SOPHiA GENETICS (NASDAQ:SOPH shareholders incur further losses as stock declines 12% this week, taking one-year losses to 75%
SOPHiA GENETICS SA ( NASDAQ:SOPH ) shareholders will doubtless be very grateful to see the share price up 45% in the...
Simply Wall St. · 08/16 12:45
BRIEF-Sophia Genetics SA Files For Mixed Shelf Of Up To $200 Mln
BRIEF-Sophia Genetics SA Files For Mixed Shelf Of Up To $200 Mln
Reuters · 08/09 21:53
SOPHiA GENETICS SA (SOPH) Reports Q2 Loss, Lags Revenue Estimates
SOPHiA GENETICS SA (SOPH) delivered earnings and revenue surprises of 0% and 0.88%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/09 12:35
Sophia Genetics: Q2 Earnings Insights
  Sophia Genetics (NASDAQ:SOPH) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Benzinga · 08/09 12:18
BRIEF-Sophia Genetics Reports Financial Results For The Second Quarter Of Fiscal 2022
BRIEF-Sophia Genetics Reports Financial Results For The Second Quarter Of Fiscal 2022
Reuters · 08/09 11:48
SOPHiA Genetics GAAP EPS of -$0.39 in-line, revenue of $11.7M misses by $0.25M
SOPHiA Genetics press release (<span class="ticker-hover-wrapp...
Seekingalpha · 08/09 11:23
Sophia Genetics Q2 EPS $(0.31) Beats $(0.39) Estimate, Sales $11.70M Miss $11.95M Estimate
Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.39) by 20.51 percent. This is unchanged from the same period last year. The company reported
Benzinga · 08/09 11:08
SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2022
Steady Operational Performance Amidst Macroeconomic HeadwindsBOSTON and LAUSANNE, Switzerland, Aug. 09, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today reported financial results fo...
GlobeNewswire · 08/09 11:05
SOPHiA GENETICS to Host Investor Day on September 20, 2022, in New York City
BOSTON and LAUSANNE, Switzerland, Aug. 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today it will host its first-ever Investor Day on Tuesday, September 20, 2022, at PUBL...
GlobeNewswire · 08/04 14:16
SOPHiA GENETICS to Participate in Canaccord Genuity 42nd Annual Growth Conference
BOSTON and LAUSANNE, Switzerland, July 29, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, announced today Chief Financial Officer, Ross Muken, will attend and be a panelist at the Canaccord Genuity 42nd Annual...
GlobeNewswire · 07/29 11:00
We're Not Very Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Rate
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Simply Wall St. · 07/20 12:18
NexImmune, Allogene top healthcare gainers; Codexis, 10x Genomics lead losers' pack
Gainers: NexImmune (NEXI) +34%. Allogene Therapeutics ALLO <font color="...
Seekingalpha · 07/15 14:00
SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2022 on August 9, 2022
BOSTON and LAUSANNE, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the second quarter of fiscal 2022 before U.S. markets open on...
GlobeNewswire · 07/14 11:00
37 Stocks Moving In Thursday's Mid-Day Session
 Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares jumped 153% to $2.94 after the company announced it received notification of euro 782.1 million of funding from the Greek State for the IPCEI Green HiPo project.
Benzinga · 06/16 16:43
Bone Biologics, Akero top healthcare gainers; AC Immune, Arcellx lead losers' pack
Gainers: Bone Biologics (BBLG) +13%. Akero Therapeutics AKRO +10%. Biotricity (BTCY) +9%. Jasper Therapeutics (JSPR) +7%. Burning Rock Biotech (BNR) +6%. Losers: AC Immune ACIU -17%. Arcellx ACLX -17%. SOPHiA GENETICS (SOPH) -16%. AirSculpt Technologies (A...
Seekingalpha · 06/16 14:08
SOPHiA GENETICS Publishes Results of 2022 Annual General Meeting
SOPHiA GENETICS SA (Nasdaq: SOPH) ("the Company"), is pleased to announce the Annual General Meeting ("the Meeting") was held at the Company's headquarters, rue du Centre 172, 1025 St-Sulpice, VD, Switzerland, earlier today at 2:00 p.m. CET (8:00 a.m. EDT)...
PR Newswire · 06/15 16:15
More
Webull provides a variety of real-time SOPH stock news. You can receive the latest news about Sophia Genetics Sa through multiple platforms. This information may help you make smarter investment decisions.
About SOPH
Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.